BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 15, Issue 11
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study
©The Author(s) 2025.
World J Psychiatry. Nov 19, 2025; 15(11): 111807
Published online Nov 19, 2025. doi: 10.5498/wjp.v15.i11.111807
Table 3 Characteristics of medication use in bipolar disorder patients, n (%)
Adjunctive antipsychotic medication
Lithium (n = 78)
Valproic acid (n = 52)
χ2
P value
None30 (41.0)18 (34.6)9.7210.205
Quetiapine15 (19.2)11 (21.2)
Olanzapine16 (20.5)4 (7.7)
Aripiprazole11 (14.1)7 (13.5)
Paliperidone0 (0)5 (9.6)
Risperidone2 (2.6)5 (9.6)
Clozapine0 (0)1 (1.9)
Amisulpride1 (1.3)0 (0)
Haloperidol1 (1.3)1 (1.9)
χ2 test were used.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.